 Home > Active Ingredient News > Antitumor Therapy > FDA awards Disitamab Vedotin (RC48) "breakthrough therapy" for the treatment of urinary endocrine cell carcinoma

FDA awards Disitamab Vedotin (RC48) "breakthrough therapy" for the treatment of urinary endocrine cell carcinoma

 Last Update: 2020-10-05
 Source: Internet
 Author: User

Tags

nucynta drug

baclofen drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The most common form of urinary tract cancer is urinary cortectal cell carcinoma, which used to be called a type-shifting cortectal cell carcinoma.
urinary tract epithelials are widely found in the kidneys, ureter, bladder and urethra.
Pharmaceutical Company RemeGen announced today that the U.S. Food and Drug Administration (FDA) has awarded the new humanized anti-HER2 antibody drug co-ed (ADC) Disitamab Vedotin (RC48) the "breakthrough therapy title."
Disitamab Vedotin (RC48) is expected to be used as a second-line therapy for HER2-positive patients with localized advanced or metastatic genitourinary endocrine cell carcinoma (UC), who have previously received chemotherapy with platinum.
, RemeGen announced that the FDA had approved a new research drug (IND) application for Phase II clinical studies in the United States and awarded Disitamab vedotin the fast-track title.
RemeGen CEO and Chief Operating Officer, Dr. Jianmin Fang said, "By 2020, there are expected to be 81,400 new cases of urinary endocrine cell carcinoma and 17,980 deaths in the United States.
high prevalence of metastatic genitourinary cell carcinoma highlights medical needs.
We look forward to working with the FDA to promote the clinical development of Disitamab Vedotin."
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

High Quality Resveratrol 99% powder 501-36-0 Shaanxi Dideu Medichem Co.Ltd

CAS No.: 501-36-0

Chemical Grade

$1/KG FOB

High purity Epirubicin hydrochloride 98% with best price 56390-09-1 and Epirubicin hydrochloride raw powder

CAS No.: 56390-09-1

Pharmacy Grade

$8.8-10/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.